BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1602 related articles for article (PubMed ID: 10901307)

  • 1. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin.
    Colwell CW; Froimson MI; Mont MA; Ritter MA; Trousdale RT; Buehler KC; Spitzer A; Donaldson TK; Padgett DE
    J Bone Joint Surg Am; 2010 Mar; 92(3):527-35. PubMed ID: 20194309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty.
    Sarmiento A; Goswami AD
    J Bone Joint Surg Am; 1999 Mar; 81(3):339-46. PubMed ID: 10199271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
    Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
    J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
    Imperiale TF; Speroff T
    JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolic disease after hybrid hip arthroplasty with negative duplex screening.
    Beuhler KO; D'Lima DD; Colwell CW; Otis SM; Walker RH
    Clin Orthop Relat Res; 1999 Apr; (361):168-77. PubMed ID: 10212610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
    Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
    J Bone Joint Surg Am; 1994 Aug; 76(8):1174-85. PubMed ID: 8056798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
    Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
    Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.
    Vulcano E; Gesell M; Esposito A; Ma Y; Memtsoudis SG; Gonzalez Della Valle A
    Int Orthop; 2012 Oct; 36(10):1995-2002. PubMed ID: 22684546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
    Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Butcher M; Brant RF; Ghali WA; Bergqvist D; Raskob GE
    Ann Intern Med; 2001 Nov; 135(10):858-69. PubMed ID: 11712876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal pulmonary embolism following elective total hip arthroplasty: a 12-year study.
    Bayley E; Brown S; Bhamber NS; Howard PW
    Bone Joint J; 2016 May; 98-B(5):585-8. PubMed ID: 27143726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
    Brookenthal KR; Freedman KB; Lotke PA; Fitzgerald RH; Lonner JH
    J Arthroplasty; 2001 Apr; 16(3):293-300. PubMed ID: 11307125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.